Frontier Science Research Center, University of Miyazaki, Miyazaki, Japan.
Br J Pharmacol. 2012 May;166(1):137-50. doi: 10.1111/j.1476-5381.2011.01803.x.
The extracellular loops (ECLs) in Family A GPCRs are important for ligand binding and receptor activation, but little is known about the function of Family B GPCR ECLs, especially ECL3. Calcitonin receptor-like receptor (CLR), a Family B GPCR, functions as a calcitonin gene-related peptide (CGRP) and an adrenomedullin (AM) receptor in association with three receptor activity-modifying proteins (RAMPs). Here, we examined the function of the ECL3 of human CLR within the CGRP and AM receptors.
A CLR ECL3 chimera, in which the ECL3 of CLR was substituted with that of VPAC2 (a Family B GPCR that is unable to interact with RAMPs), and CLR ECL3 point mutants were constructed and transiently transfected into HEK-293 cells along with each RAMP. Cell-surface expression of each receptor complex was then measured by flow cytometry; [(125) I]-CGRP and [(125) I]-AM binding and intracellular cAMP accumulation were also measured.
Co-expression of the CLR ECL3 chimera with RAMP2 or RAMP3 led to significant reductions in the induction of cAMP signalling by AM, but CGRP signalling was barely affected, despite normal cell-surface expression of the receptors and normal [(125) I]-AM binding. The chimera had significantly decreased AM, but not CGRP, responses in the presence of RAMP1. Not all CLR ECL3 mutants supported these findings.
The human CLR ECL3 is crucial for AM-induced cAMP responses via three CLR/RAMP heterodimers, and activation of these heterodimers probably relies on AM-induced conformational changes. This study provides a clue to the molecular basis of the activation of RAMP-based Family B GPCRs.
A 类 G 蛋白偶联受体(GPCR)的细胞外环(ECL)对于配体结合和受体激活很重要,但关于 B 类 GPCR 的 ECL 功能,尤其是 ECL3 的功能知之甚少。降钙素受体样受体(CLR)是一种 B 类 GPCR,它与三种受体活性修饰蛋白(RAMP)结合,作为降钙素基因相关肽(CGRP)和肾上腺髓质素(AM)受体发挥作用。在这里,我们研究了人 CLR 的 ECL3 在 CGRP 和 AM 受体中的功能。
构建了 CLR ECL3 嵌合体,其中 CLR 的 ECL3 被替换为 VPAC2 的 ECL3(一种不能与 RAMP 相互作用的 B 类 GPCR),并构建了 CLR ECL3 点突变体,与每种 RAMP 一起瞬时转染到 HEK-293 细胞中。然后通过流式细胞术测量每个受体复合物的细胞表面表达;还测量了[125]I-CGRP 和[125]I-AM 的结合和细胞内 cAMP 积累。
与 RAMP2 或 RAMP3 共表达 CLR ECL3 嵌合体导致 AM 诱导的 cAMP 信号转导显著降低,但 CGRP 信号转导几乎不受影响,尽管受体的细胞表面表达正常,[125]I-AM 结合正常。该嵌合体在存在 RAMP1 的情况下具有显著降低的 AM,但不是 CGRP 的反应。并非所有 CLR ECL3 突变体都支持这些发现。
人 CLR ECL3 对于通过三种 CLR/RAMP 异源二聚体诱导的 AM 诱导的 cAMP 反应至关重要,并且这些异源二聚体的激活可能依赖于 AM 诱导的构象变化。本研究为基于 RAMP 的 B 类 GPCR 激活的分子基础提供了线索。